Although many studies illustrated that LECT2 as a potential tumor suppressor in liver cancer, the detailed antitumor mechanism of LECT2 on HCC, especially hepatic cancer stem cells (CSCs) has remained largely unclear. Here, LECT2 is linked to neoplasm.